{{scheme.chgp}}%
{{scheme.chgp}}%
No Matches Found
{{scheme.chgp}}%
No Matches Found
No Matches Found
Alphatec Holdings, Inc.
Alphatec Holdings Hits New 52-Week High of $20.14
Alphatec Holdings, Inc. has achieved a new 52-week high of USD 20.14, reflecting an impressive one-year performance of 85.27%. With a market capitalization of USD 2,448 million, the company operates in a competitive pharmaceuticals and biotechnology sector, despite facing challenges such as a negative return on equity.
Alphatec Holdings Hits New 52-Week High at $17.14
Alphatec Holdings, Inc. has achieved a new 52-week high of USD 17.14, significantly up from its low of USD 5.36, reflecting a year-over-year performance improvement. With a market cap of USD 2,448 million, the company faces challenges, including a high debt-to-equity ratio and negative return on equity.
Alphatec Holdings, Inc. Experiences Revision in Stock Evaluation Amid Market Dynamics
Alphatec Holdings, Inc. has recently revised its evaluation amid changing market dynamics. The stock, priced at $13.60, has shown impressive performance over the past year with a return of 147.72%. Technical indicators present a mixed outlook, reflecting both bullish and bearish trends in the market.
Is Alphatec Holdings, Inc. technically bullish or bearish?
As of October 3, 2025, Alphatec Holdings, Inc. shows a mildly bullish trend overall, with mixed signals from MACD indicators and moving averages, while underperforming the S&P 500 recently but significantly outperforming it year-to-date.
Is Alphatec Holdings, Inc. technically bullish or bearish?
As of October 3, 2025, Alphatec Holdings, Inc. has a mildly bullish technical trend, supported by bullish MACD indicators and Bollinger Bands, despite mixed signals from Dow Theory and underperformance against the S&P 500 in the short term.
Is Alphatec Holdings, Inc. technically bullish or bearish?
As of October 3, 2025, Alphatec Holdings, Inc. shows a mildly bullish technical trend with strong monthly indicators, despite mixed weekly signals and recent underperformance compared to the S&P 500.
Is Alphatec Holdings, Inc. technically bullish or bearish?
As of August 4, 2025, Alphatec Holdings, Inc. shows a bullish technical trend supported by positive indicators, despite some mixed signals, and has significantly outperformed the S&P 500 with a year-to-date return of 65.80% compared to 12.22%.
Is Alphatec Holdings, Inc. technically bullish or bearish?
As of June 13, 2025, Alphatec Holdings, Inc. shows a mildly bullish trend overall, supported by daily moving averages and bullish momentum indicators, despite some mixed signals from weekly MACD and Bollinger Bands suggesting caution.
Who are in the management team of Alphatec Holdings, Inc.?
As of March 2022, the management team of Alphatec Holdings, Inc. includes Patrick Miles (Chairman, President, CEO), Mortimer Berkowitz (Lead Independent Director), David Pelizzon, Jeffrey Rydin, Evan Bakst, and Quentin Blackford (all Directors).
What does Alphatec Holdings, Inc. do?
Alphatec Holdings, Inc. is a medical technology company focused on products for spine disorder surgeries, with recent net sales of $169 million and a net loss of $52 million. It operates as a small-cap company with a market cap of approximately $1.61 billion.
How big is Alphatec Holdings, Inc.?
As of Jun 18, Alphatec Holdings, Inc. has a market capitalization of $1.61 billion, classifying it as a Small Cap company. The latest four quarters show net sales of $642.26 million and a net profit of -$165.54 million.
{{list.post_title}}
{{list.post_excerpt}}
{{list.post_title}}
{{list.post_excerpt}}
